missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human RIMKLA (aa 297-389) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (68%), Rat (68%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-55705 (PA5-55705. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Catalyzes the synthesis of N-acetyl-L-aspartyl-L-glutamate (NAAG) and N-acetyl-L-aspartyl-L-glutamyl-L-glutamate.
Specifications
Specifications
| Accession Number | Q8IXN7 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 284716 |
| Name | Human RIMKLA (aa 297-389) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | B930030J24; Fam80a; family with sequence similarity 80, member A; NAAG synthetase A; NAAGS; NAAGS-II; N-acetylaspartylglutamate synthase A; N-acetylaspartyl-glutamate synthetase A; N-acetylaspartylglutamate synthetase II; N-acetylaspartylglutamylglutamate synthase A; ribosomal modification protein rimK like family member A; ribosomal modification protein rimK-like family member A; ribosomal protein S6 modification-like protein A; Rimk; Rimkla; RP11-157D18.1 |
| Common Name | RIMKLA |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction